« Previous
Next »
Titles
- ACF should improve oversight of head start to better protect children’s safety1
- CMS has opportunities to strengthen states’ oversight of Medicaid Managed Care Plans’ reporting of medical loss ratios1
- CMS should bolster its oversight of manufacturer-submitted average sales price data to ensure accurate Part B drug payments1
- Certain Medicare beneficiaries, such as urban and Hispanic beneficiaries, were more likely than others to use telehealth during the first year of the COVID-19 pandemic1
- Connecticut Medicaid Fraud Control Unit: 2021 inspection1
- During the initial COVID-19 response, HHS personnel who interacted with potentially infected passengers had limited protections1
- FDA repeatedly adapted emergency use authorization policies to address the need for COVID-19 testing1
- FDA’s approach to overseeing online tobacco retailers needs improvement1
- FDA’s work with the tri-agency task force for emergency diagnostics helped labs implement COVID-19 tests1
- For Medicaid-enrolled children diagnosed with lead toxicity in five states, documentation reviewed for diagnoses and treatment services raises concerns1
- Home health agencies used multiple strategies to respond to the COVID-19 pandemic, although some challenges persist1
- In five states, there was no evidence that many children in foster care had a screening for sex trafficking when they returned after going missing1
- Inaccuracies in Medicare’s race and ethnicity data hinder the ability to assess health disparities1
- Iowa Medicaid Fraud Control Unit: 2021 inspection1
- Long-term trends of psychotropic drug use in nursing homes1
- Manufacturers may need additional guidance to ensure consistent calculations of average sales prices1
- Medicare Part B drug payments: impact of price substitutions based on 2020 average sales prices1
- Medicare Part B spending on lab tests increased in 2021, driven by higher volume of COVID-19 tests, genetic tests, and chemistry tests1
- Medicare telehealth services during the first year of the pandemic: program integrity risks1
- Michigan Medicaid Fraud Control Unit: 2021 review1